Capula Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Capula Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,380	Closed	-$220K	–	833
2021 Q3	$220K	Buy	+3,380	New	+$231K	﹤0.01%	778

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Capula Management's AXNX Position: Q4 2021 in Review

Capula Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2021, closing a stake of 3,380 shares — an estimated $220K sold.

Capula Management first reported a position in AXNX in Q3 2021 and held it in 1 quarter. The position peaked at $220K in Q3 2021. 180 funds tracked by Wall St. Rank hold AXNX as of Q4 2021.

Capula Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Capula Management sold 3,380 Axonics, Inc. Common Stock shares in Q4 2021, an estimated $220K.
Capula Management first reported a position in Axonics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
Capula Management's Axonics, Inc. Common Stock position peaked at $220K in Q3 2021.
180 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2021.

Based on Capula Management's 13F filing for Q4 2021, filed 14 Feb 2022.